Bio-Gene Technology Limited (BGT.AX)
AUD 0.03
(-10.71%)
AUD 0.03
(-10.71%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 2.76 Million AUD | -26.9% |
| 2023 | 3.77 Million AUD | -1.98% |
| 2022 | 3.85 Million AUD | 26.82% |
| 2021 | 3.03 Million AUD | -0.98% |
| 2020 | 3.06 Million AUD | 13.64% |
| 2019 | 2.7 Million AUD | -0.9% |
| 2018 | 2.72 Million AUD | 279.43% |
| 2017 | 718.11 Thousand AUD | 45.62% |
| 2016 | 493.12 Thousand AUD | 175.95% |
| 2015 | 178.7 Thousand AUD | 29.92% |
| 2014 | 137.54 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.16 Million AUD | 0.0% |
| 2024 FY | 2.76 Million AUD | -26.9% |
| 2024 Q4 | 1.59 Million AUD | 0.0% |
| 2023 Q2 | 2.03 Million AUD | 0.0% |
| 2023 FY | 3.77 Million AUD | -1.98% |
| 2023 Q4 | 1.42 Million AUD | 0.0% |
| 2022 Q2 | 1.73 Million AUD | 0.0% |
| 2022 FY | 3.85 Million AUD | 26.82% |
| 2022 Q4 | 1.84 Million AUD | 0.0% |
| 2021 Q4 | 1.51 Million AUD | 0.0% |
| 2021 Q1 | 342.86 Thousand AUD | -73.04% |
| 2021 FY | 3.03 Million AUD | -0.98% |
| 2021 Q2 | 1.34 Million AUD | 292.96% |
| 2020 Q2 | 1.53 Million AUD | 0.0% |
| 2020 Q4 | 1.27 Million AUD | 270.96% |
| 2020 Q3 | 342.86 Thousand AUD | -77.68% |
| 2020 FY | 3.06 Million AUD | 13.64% |
| 2019 Q3 | 267.57 Thousand AUD | -79.62% |
| 2019 FY | 2.7 Million AUD | -0.9% |
| 2019 Q4 | 1.3 Million AUD | 386.89% |
| 2019 Q2 | 1.31 Million AUD | 0.0% |
| 2018 Q4 | 1.68 Million AUD | 560.39% |
| 2018 FY | 2.72 Million AUD | 279.43% |
| 2018 Q2 | 1.56 Million AUD | 0.0% |
| 2018 Q3 | 255.27 Thousand AUD | -83.69% |
| 2017 Q4 | 835.78 Thousand AUD | 0.0% |
| 2017 FY | 718.11 Thousand AUD | 45.62% |
| 2017 Q2 | 300.68 Thousand AUD | 0.0% |
| 2016 FY | 493.12 Thousand AUD | 175.95% |
| 2015 FY | 178.7 Thousand AUD | 29.92% |
| 2014 FY | 137.54 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | 59.214% |
| Acrux Limited | 8.55 Million AUD | 67.707% |
| Actinogen Medical Limited | 22.77 Million AUD | 87.875% |
| AnteoTech Limited | 12.18 Million AUD | 77.345% |
| Argenica Therapeutics Limited | 8.26 Million AUD | 66.611% |
| Arovella Therapeutics Limited | 10.78 Million AUD | 74.4% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -288.756% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 88.204% |
| Amplia Therapeutics Limited | 8.43 Million AUD | 67.27% |
| Avecho Biotechnology Limited | 4.54 Million AUD | 39.257% |
| Biome Australia Limited | 7.91 Million AUD | 65.1% |
| Biotron Limited | 5.11 Million AUD | 45.976% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -358.777% |
| BTC Health Limited | -1.03 Million AUD | 365.756% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | 86.032% |
| CSL Limited | 7.56 Billion AUD | 99.963% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 95.097% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 91.178% |
| Cynata Therapeutics Limited | 11.12 Million AUD | 75.179% |
| Dimerix Limited | 25.64 Million AUD | 89.233% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 93.023% |
| Hexima Limited | 1 Million AUD | -173.706% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | 33.072% |
| Immuron Limited | 9.13 Million AUD | 69.785% |
| Immutep Limited | 42.87 Million AUD | 93.56% |
| Imugene Limited | 135.09 Million AUD | 97.956% |
| Invex Therapeutics Ltd | 3.34 Million AUD | 17.48% |
| Memphasys Limited | 3.67 Million AUD | 24.939% |
| Nanollose Limited | 12.5 Thousand AUD | -21986.345% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 91.556% |
| Noxopharm Limited | 7 Million AUD | 60.558% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -40.494% |
| Nyrada Inc. | 4.55 Million AUD | 39.387% |
| Orthocell Limited | 15.36 Million AUD | 82.036% |
| PharmAust Limited | 6.65 Million AUD | 58.525% |
| Patrys Limited | 4.93 Million AUD | 44.033% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 95.759% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -209.481% |
| Prescient Therapeutics Limited | 10.89 Million AUD | 74.667% |
| PYC Therapeutics Limited | 60.91 Million AUD | 95.468% |
| Race Oncology Limited | 14.77 Million AUD | 81.307% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -822.712% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | 87.267% |
| Starpharma Holdings Limited | 22.81 Million AUD | 87.899% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 98.975% |
| Tissue Repair Ltd | 6.66 Million AUD | 58.586% |
| Zelira Therapeutics Limited | 5.94 Million AUD | 53.585% |